(Q45305057)

11 December 2017

Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington's disease (English)

1 reference

11 December 2017

0 references

0 references

Clifford JJ

1

1 reference

11 December 2017

Drago J

2

1 reference

11 December 2017

Natoli AL

3

1 reference

11 December 2017

Wong JY

4

1 reference

11 December 2017

Kinsella A

5

1 reference

11 December 2017

Waddington JL

6

1 reference

11 December 2017

Vaddadi KS

7

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

11 December 2017

1 reference

11 December 2017

109

1 reference

11 December 2017

1

1 reference

11 December 2017

81-88

1 reference

Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Topographical evaluation of the phenotype of spontaneous behaviour in mice with targeted gene deletion of the D1A dopamine receptor: paradoxical elevation of grooming syntax.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Topographical evaluation of behavioural phenotype in a line of mice with targeted gene deletion of the D2 dopamine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Comparative, topographically-based evaluation of behavioural phenotype and specification of D(1)-like:D(2) interactions in a line of incipient congenic mice with D(2) dopamine receptor 'knockout'

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

The antidyskinetic action of dihomo-gamma-linolenic acid in the rodent

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Genetics of mouse behavior: interactions with laboratory environment.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Targeted expression of a toxin gene to D1 dopamine receptor neurons by cre-mediated site-specific recombination.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Purification and characterisation of phospholipase A2 from human epidermis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

1 reference

7 January 2021

The gait abnormality of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Schizophrenic symptoms and dietary intake of n-3 fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Essential fatty acids and abnormal involuntary movements in the general male population: a study of men born in 1933

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

The nervous system has an absolute molecular species requirement for proper function

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Dyskinesias and their treatment with essential fatty acids: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

Delaying the onset of Huntington's in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900409-2

7 January 2021

10.1016/S0306-4522(01)00409-2

Identifiers

DOI

1 reference

11 December 2017

1 reference